about
Quinine induces reversible high-tone hearing lossIn vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondiiCardiac alterations in human African trypanosomiasis (T.b. gambiense) with respect to the disease stage and antiparasitic treatmentDivided-dose kinetics of mefloquine in manAntimalarial pharmacokinetics and treatment regimens.Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.Prophylaxis for malaria. Helping world travelers come home healthy.Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated plasmodium falciparum malaria.Quinine uptake by human polymorphonuclear neutrophils.Reversed siderophores act as antimalarial agents.Treatment of malaria: some considerations and limitations of the current methods of assessment.Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor.Suicidal chloroquine poisoning: report of two cases.The parenteral controlled release of liposome encapsulated chloroquine in mice.An improved formulation of chloroquine for intramuscular administration: absorption kinetics in rabbits.Chloroquine containing liposomes in the chemotherapy of murine malaria.Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.The effect of metoclopramide on mefloquine pharmacokinetics.Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers.
P2860
Q28331125-5E64369B-910B-4BFA-B79C-7FAAB2A6F672Q28369470-8CDB3CC3-B419-4415-A986-5AF8CFDC82EEQ28474798-B8E3B133-1EA3-43A2-A78D-962E7F2243C8Q34397598-472AB411-5337-4093-8DA7-D1E395B13D3BQ34403100-5C10F660-44A8-4738-8071-B03B56AD4AD4Q35244822-C7084863-729A-40B5-9724-0A0E812A66B8Q35799031-C90C041A-6104-4BAB-8525-9F2334A9856AQ36752995-E4706769-740E-4317-9380-F21D427326DDQ36754287-DD6B7666-1D4F-4259-9C83-9A766A060619Q37557713-CB60B427-0101-43A7-95B7-26CBF959144BQ38761558-0B2077DE-C127-44B0-A831-FE2A1AFF0B65Q41929179-B6DBF13D-366F-4464-A170-28A7074EBD28Q41934602-37A18EAF-F739-47EA-BDE4-7FBB69021521Q41943573-50A2183A-3217-40C7-AEA4-43F0035295D3Q41945266-084CF705-4493-466F-A609-AD3671CEBF2FQ41945801-3D50C733-1FA4-43EB-A569-137C6587FA4EQ42705839-668AA40E-FB0B-43A5-898B-0053F612624AQ43205192-02F4FADC-F478-4D50-BBA2-B1A54ABA4F74Q46492467-7C5A7F34-47EA-4875-8D28-2512CD811B60
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Drug treatment and prevention of malaria.
@en
Drug treatment and prevention of malaria.
@nl
type
label
Drug treatment and prevention of malaria.
@en
Drug treatment and prevention of malaria.
@nl
prefLabel
Drug treatment and prevention of malaria.
@en
Drug treatment and prevention of malaria.
@nl
P2860
P356
P1476
Drug treatment and prevention of malaria.
@en
P2860
P2888
P356
10.1007/BF01061409
P577
1988-01-01T00:00:00Z